Cargando…
RHOA mutation in diffuse-type gastric cancer: a comparative clinicopathology analysis of 87 cases
BACKGROUND: Recent studies have discovered recurrent RHOA mutations in diffuse-type gastric cancers. These reports show mutant RhoA is an important cancer driver and is a potential therapeutic target. This study aims to investigate the clinicopathological features of diffuse-type gastric cancers wit...
Autores principales: | Ushiku, Tetsuo, Ishikawa, Shumpei, Kakiuchi, Miwako, Tanaka, Atsushi, Katoh, Hiroto, Aburatani, Hiroyuki, Lauwers, Gregory Y., Fukayama, Masashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824805/ https://www.ncbi.nlm.nih.gov/pubmed/25823974 http://dx.doi.org/10.1007/s10120-015-0493-0 |
Ejemplares similares
-
Frequent CLDN18-ARHGAP fusion in highly metastatic diffuse-type gastric cancer with relatively early onset
por: Tanaka, Atsushi, et al.
Publicado: (2018) -
Coupling CDH17 and CLDN18 markers for comprehensive membrane-targeted detection of human gastric cancer
por: Matsusaka, Keisuke, et al.
Publicado: (2016) -
Defined lifestyle and germline factors predispose Asian populations to gastric cancer
por: Suzuki, Akihiro, et al.
Publicado: (2020) -
DGC-specific RHOA mutations maintained cancer cell survival and promoted cell migration via ROCK inactivation
por: Nishizawa, Takashi, et al.
Publicado: (2018) -
Tumor Content Chart-Assisted HER2/CEP17 Digital PCR Analysis of Gastric Cancer Biopsy Specimens
por: Matsusaka, Keisuke, et al.
Publicado: (2016)